@inproceedings{inproceedings, title  = {{PRO15 COST-EFFECTIVENESS OF NUSINERSEN AND ONASEMNOGENE ABEPARVOVEC FOR INFANTILE-ONSET SPINAL MUSCULAR ATROPHY (TYPE I SMA) IN THE US}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2019}},

 month = {{5}},

 author = {{Thokala P and Stevenson M and Kumar VM and Ren S and Chapman R and Ellis A and Rind D}},

 doi = {{10.1016/j.jval.2019.04.1648}},

 volume = {{22}},

 journal = {{Value in Health}},

 pages = {{S337-S338}},

 note = {{Accessed on 2024/10/18}}}